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The process of endochondral ossification in which the bones of the limb are formed after generation of cartilage models is
dependent on a precisely regulated program of chondrocyte maturation. Here, we show that the homeobox-containing gene
Dlx5 is expressed at the onset of chondrocyte maturation during the conversion of immature proliferating chondrocytes into
postmitotic hypertrophying chondrocytes, a critical step in the maturation process. Moreover, retroviral misexpression of
Dlx5 during differentiation of the skeletal elements of the chick limb in vivo results in the formation of severely shortened
skeletal elements that contain excessive numbers of hypertrophying chondrocytes which extend into ectopic regions,
including sites normally occupied by immature chondrocytes. The expansion in the extent of hypertrophic maturation
detectable histologically is accompanied by expanded and upregulated domains of expression of molecular markers of
chondrocyte maturation, particularly type X collagen and osteopontin, and by expansion of mineralized cartilage matrix,
which is characteristic of terminal hypertrophic differentiation. Furthermore, Dlx5 misexpression markedly reduces
chondrocyte proliferation concomitant with promoting hypertrophic maturation. Taken together, these results indicate
that Dlx5 is a positive regulator of chondrocyte maturation and suggest that it regulates the process at least in part by
promoting conversion of immature proliferating chondrocytes into hypertrophying chondrocytes. Retroviral misexpression
of Dlx5 also enhances formation of periosteal bone, which is derived from the Dlx5-expressing perichondrium that
surrounds the diaphyses of the cartilage models. This suggests that Dlx5 may be involved in regulating osteoblast
differentiation, as well as chondrocyte maturation, during endochondral ossification. © 2002 Elsevier Science (USA)
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The skeletal elements of the limb develop by a process
called endochondral ossification in which bone is formed
after the establishment of a cartilaginous template (Olsen et
al., 2000; de Crombrugghe et al., 2001; Wagner and
Karsenty, 2001). At the onset of this process, mesenchymal
cells in discrete regions of the developing limb bud aggre-
gate into precartilage condensations which prefigure the
future skeletal elements. The cartilage anlagen undergo
rapid longitudinal and appositional growth as a result of
proliferation and matrix deposition to form the cartilage
models of the bones of the limb. The developing cartilage
models become surrounded by a longitudinally oriented
group of flattened cells called the perichondrium. Interac-
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All rights reserved.tions between the perichondrium and chondrocytes of the
cartilage model play a major role in regulating various
aspects of endochondral ossification (Long and Linsen-
mayer, 1998; Di Nino et al., 2001).
Chondrocytes within the cartilage models progressively
undergo a precisely regulated and coordinated program of
maturation from proliferating to prehypertrophic to hyper-
trophic chondrocytes (Olsen et al., 2000; de Crombrugghe
et al., 2001; Wagner and Karsenty, 2001). Maturation com-
mences in the central regions or diaphyses of the cartilage
models where immature chondrocytes exit the cell cycle,
enlarge, and are converted into prehypertrophic chondro-
cytes which are characterized by the expression of the
secreted signaling molecule Indian hedgehog (Ihh) (Vort-
kamp et al., 1996). The prehypertrophic chondrocytes un-
dergo further differentiation to hypertrophic chondrocytes
during which they continue to enlarge, initiate expression
of type X collagen and other hypertrophic markers, includ-
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ing osteopontin and bone sialoprotein, and deposit a min-
eralized matrix. In parallel with the differentiation of hy-
pertrophying chondrocytes, the perichondrium flanking the
maturing chondrocytes becomes the periosteum, which is
the source of osteogenic cells that deposit a bony collar
around the diaphyses of the cartilage rudiments (Pechak et
al., 1986a). Blood vessels arising from the periosteum in-
vade into the area of chondrocyte hypertrophy, a process
dependent on vascular endothelial growth factor (VEGF)
expressed by hypertrophic chondrocytes (Gerber et al.,
1999). Vascular invasion of the hypertrophic zone is accom-
panied by degradation and resorption of the mineralized
cartilage matrix, its replacement by trabecular bone depos-
ited by invading osteoblasts, and the concomitant excava-
tion of the bone marrow cavity. The continued maturation
of immature proliferating chondrocytes into hypertrophy-
ing chondrocytes and their replacement by trabecular bone
and bone marrow results in the longitudinal growth of the
long bones. Thus, a critical step in the longitudinal growth
of long bones and endochondral ossification is the conver-
sion of immature proliferating chondrocytes into hypertro-
phying chondrocytes. Indeed, hypertrophic maturation ap-
pears to be the main determinant of longitudinal growth
(Hunziker, 1994).
The rate and progression of hypertrophic chondrocyte
maturation during endochondral ossification is regulated by
a coordinated balance between negative and positive sig-
nals. Ihh and parathyroid hormone-related peptide (PTHrP)
function in a regulatory loop to negatively control chondro-
cyte maturation (Vortkamp et al., 1996; Kronenberg et al.,
1997; St-Jacques et al., 1999). In particular, Ihh expressed by
newly postmitotic prehypertrophic chondrocytes induces
PTHrP expression in the periarticular perichondrium adja-
cent to the immature proliferating chondrocytes in the
epiphysis. In turn, PTHrP signals via its receptor PTH/
PTHrP-R to suppress the maturation of proliferating chon-
drocytes in the subjacent epiphysis, thus maintaining a
zone of immature chondrocytes competent to undergo
proliferation (Vortkamp et al., 1996; Kronenberg et al.,
1997; St-Jacques et al., 1999). Members of the TGF- family
produced by the perichondrium have also been implicated
as negative regulators of chondrocyte maturation (Serra et
al., 1997) and may act upstream of PTHrP to suppress the
process (Serra et al., 1999). In addition, the transition from
prehypertrophic to hypertrophic chondrocytes is negatively
controlled by Wnt-5a produced by the perichondrium (Hart-
mann and Tabin, 2000) and by the Notch receptor ligand
Delta-1 produced by hypertrophic chondrocytes (Crowe et
al., 1999).
Recently, several positive regulators of chondrocyte
maturation have been identified. These include one or more
members of the BMP family (Enomoto-Iwamoto et al.,
1998; Volk et al., 2000; Pathi et al., 1999; Minina et al.,
2001), particularly BMP-6 (Grimsrud et al., 1999; Ito et al.,
1999; Kameda et al., 2000; Boskey et al., 2002), which is
specifically expressed by the prehypertrophic and hypertro-
phic chondrocytes (Kingsley, 1994; Vortkamp et al., 1996;
Inada et al., 1999). Wnt-4 expressed by cells flanking the
epiphysis of the cartilage models has also been implicated
in the positive control of maturation (Hartmann and Tabin,
2000), and gain- and loss-of-function studies in vitro and in
vivo have shown that the transcription factor Cbfa1/Runx2
expressed by prehypertrophic and hypertrophic chondro-
cytes is an important positive regulator of the maturation
process (Inada et al., 1999; Kim et al., 1999 Enomoto et al.,
2000; Takeda et al., 2001; Ueta et al., 2001; Leboy et al.,
2001).
Identification of the regulatory genes and signaling mol-
ecules that control the progression of chondrocyte matura-
tion toward hypertrophy and the regulatory interactions
among them is crucial to understanding normal and abnor-
mal bone growth and development. In the present study, we
provide evidence indicating that the homeodomain tran-
scription factor Dlx5 is an important positive regulator of
chondrocyte maturation during endochondral ossification.
Dlx5 is one of six members of the Dlx family of homeobox-
containing genes that are homologs of the Drosophila
Distal-less gene, which is required for limb development in
the fly embryo (Merlo et al., 2000; Zerucha and Ekker,
2000). Dlx5 has been implicated in several aspects of early
vertebrate limb morphogenesis, including specification of
the limb territories of the lateral plate, activity of the apical
ectodermal ridge which directs limb outgrowth, and pat-
terning along the anteroposterior axis (Ferrari et al., 1995,
1999). Later in development, Dlx5 is expressed by differen-
tiating osteoblasts during intramembranous and endochon-
dral ossification (Simeone et al., 1994; Zhao et al., 1994),
and several studies suggest that it may play a role in
osteoblast differentiation (Newberry et al., 1998; Miyama et
al., 1999; Benson et al., 2000; Tadic et al., 2001, 2002).
Here, we report that Dlx5 is expressed during the conver-
sion of immature proliferating chondrocytes into postmi-
totic hypertrophying chondrocytes, which is a critical step
in chondrocyte maturation during endochondral ossifica-
tion. Moreover, retroviral misexpression of Dlx5 during the
differentiation of the skeletal elements of the chick limb in
vivo promotes chondrocyte maturation, resulting in the
formation of severely shortened skeletal elements that
contain excessive numbers of hypertrophying chondro-
cytes. Our results indicate that Dlx5 positively regulates
chondrocyte maturation, and may do so at least in part by
promoting conversion of immature proliferating chondro-
cytes to hypertrophying chondrocytes.
MATERIALS AND METHODS
Preparation of Dlx5 Retroviral Expression Vector
and Infection Protocol
The methods used for the preparation and propagation of the
avian replication competent Dlx5 expression vector were essen-
tially the same as those previously described (Ferrari et al., 1998)
and follow standard established protocols (Morgan and Fekete,
1996). Briefly, our cDNA containing the full coding sequence of
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chicken Dlx5 (Ferrari et al., 1995) was cloned into the ClaI site of
RCASBP(A), a derivative of Rous Sarcoma Virus (RSV) containing a
portion of the pol gene from the Bryan high titer strain of RSV
(obtained from Steve Hughes). Chick embryo fibroblasts (CEF) were
transfected with the retroviral plasmid DNA, and the cells were
cultured until virus production was high as assayed by media
reverse transcriptase activity (Ferrari et al., 1998). Concentrated
retroviral stocks were prepared by ultracentrifugation of the virus-
containing media (Morgan and Fekete, 1996; Ferrari et al., 1998),
and aliquots were rapidly frozen. Titers were determined by adding
limiting dilutions of the concentrated retroviral stock to subcon-
fluent CEF cultures, immunostaining with a monoclonal antibody
against the RSV viral gag antigen p19, and counting the number of
positive colonies (Morgan and Fekete, 1996; Ferrari et al., 1998).
Titers ranged from 0.5 to 1  109 cfu/ml.
Concentrated Dlx5 retrovirus or control RCASBP(A) retrovirus
lacking the Dlx5 cDNA insert was microinjected as previously
described (Ferrari et al., 1998) into the proximal posterior portion of
stage 21/22 right chick wing buds, which will give rise primarily to
the humerus, ulna, and radius. This resulted in widespread Dlx5
expression detectable by in situ hybridization throughout the
proximal skeletal elements and soft tissue of the infected limbs
(data not shown). Limbs infected with control retrovirus exhibited
no detectable abnormalities.
Skeletal Staining and Histology
The skeletons of day 13–18 embryos were whole-mount stained
with Alcian blue and Alizarin Red to visualize cartilage and
mineralized bone, respectively. Older embryos were usually evis-
cerated before staining. Briefly, embryos were incubated in 0.015%
Alcian blue in 95% ethanol/20% glacial acetic acid for 2–4 days,
after which they were cleared for 2–4 days in 2% KOH. They were
then stained overnight in 0.1% Alizarin Red S in 1% KOH followed
by clearing in 0.5% KOH and a graded series of KOH/glycerine
solutions to 100% glycerine. Infected and contralateral control
limbs were removed in 100% glycerine and photographed. After
photography, some of the limbs were washed in PBS, dehydrated in
100% ethanol, cleared in xylene, embedded in paraffin, sectioned,
and stained with hematoxylin and eosin.
In Situ Hybridization
In situ hybridization on serially sectioned limbs that had been
fixed in Bouin’s solution was performed by using 33P-labeled cDNA
probes (see below) and high-stringency hybridization conditions as
previously described (Coelho et al., 1991). In order to carefully
correlate expression patterns of different genes or to compare
different parameters, in many cases, adjacent sections (within 20
m of one another) of the same specimens were mounted on
separate slides and hybridized with different probes and/or sub-
jected to different analyses (see below).
The cDNA probes used for in situ hybridization were as follows:
a 323-bp probe from the 3 untranslated region of chicken Dlx5
cDNA prepared as previously described (Ferrari et al., 1999); a
560-bp probe from the 5 end of chicken Ihh cDNA prepared by
digesting clone pcIHHR4–1 Sac (provided by Cliff Tabin) (Vort-
kamp et al., 1996) in Bluescript SK with EcoRI and SacI; a 234-bp
probe from the 5 end of chicken PTHrP cDNA prepared by
digesting clone PTHrP2 (provided by Cliff Tabin) (Vortkamp et al.,
1996) in pGEMT with NcoI and SpeI; a 1.1-kb probe corresponding
to the full coding sequence of chicken osteopontin cDNA prepared
by digesting clone pMMPP2 (provided by Louis Gerstenfeld)
(Moore et al., 1991) in Bluescript SK with EcoRI.
The cDNA probes were labeled with [33P]dCTP by the random
oligonucleotide primer procedure.
Immunohistochemistry
Immunostaining for type X collagen with monoclonal antibody
X-AC9 (Schmid and Linsenmayer, 1985) (Developmental Studies
Hybridoma Bank) on serially sectioned limbs that had been fixed in
Bouin’s solution was carried out as previously described (Kosher
and Solursh, 1989) by using a Vectastain Elite ABC Kit. Sections
were treated with 5 mg/ml bovine testicular hyaluronidase (Type
I-S; Sigma) prior to immunostaining, and staining was done with a
1:80 dilution of X-AC9 in PBS containing 5% normal horse serum.
Histochemical Analysis of Mineralization
For histochemical detection of mineralized matrix, serially sec-
tioned limbs that had been fixed in 95% ethanol were stained with
0.5% Alizarin Red S, pH 4.0, for 5 min at room temperature as
described by Yagami et al. (1999).
Analysis of Cell Proliferation
Cell proliferation was assayed immunohistochemically by stain-
ing serially sectioned limbs that had been fixed in Bouin’s solution
for PCNA (proliferating cell nuclear antigen), an accessory protein
for DNA polymerase that is present in the nuclei of dividing cells
(Hall et al., 1990; Waseem and Lane, 1990), using a monoclonal
antibody against PCNA (clone PC10) and a kit obtained from
Novacastra. Before immunostaining, sections were treated with
Vector antigen unmasking solution at 95o for 5 min, and after
immunostaining, the sections were lightly counterstained with
hematoxylin to detect unlabeled nuclei. The number of PCNA
labeled and unlabeled nuclei in four adjacent sections through the
middle of the metaphyseal region of Dlx5-infected and contralat-
eral control limbs were counted in photomicrographs.
RESULTS
Dlx5 Is Expressed at the Onset of Chondrocyte
Maturation Concomitant with the Conversion of
Immature Proliferating Chondrocytes into
Hypertrophying Chondrocytes
After the formation of the cartilage models of the long
bones of the limb, Dlx5 is highly expressed by the perichon-
drium adjacent to the diaphysis of the models that will give
rise to the osteoblasts that deposit the periosteal bony collar
(Fig. 1). As endochondral ossification proceeds, Dlx5 is
indeed very highly expressed in the inner layers of the
periosteum where osteoblasts are differentiating and depos-
iting periosteal bone (data not shown). These observations
suggest the possibility that Dlx5 may be involved in regu-
lating the onset of periosteal bone differentiation during
endochondral ossification.
In addition to being expressed by the perichondrium/
periosteum, Dlx5 is expressed by the maturing prehypertro-
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phic and hypertrophic chondrocytes in the central regions
or diaphyses of the cartilage models (Fig. 1). In contrast,
Dlx5 is not expressed by the immature proliferating chon-
drocytes in the epiphyses (Fig. 1). Thus, Dlx5 expression in
the cartilage models is initiated concomitant with the
conversion of immature proliferating chondrocytes into
postmitotic prehypertrophic chondrocytes, which is a criti-
cal step in chondrocyte maturation. This pattern of expres-
sion is suggestive of a possible role for Dlx5 in the regula-
tion of chondrocyte maturation during endochondral
ossification.
Dlx5 Misexpression during Skeletal Differentiation
in Vivo Results in the Formation of Severely
Shortened Skeletal Elements
To explore the role of Dlx5 in endochondral ossification,
we misexpressed Dlx5 during the differentiation of the
skeletal elements of the developing chick limb in ovo with
the avian replication competent retroviral vector RCASBP
to determine whether misexpression of Dlx5 modified the
process of chondrocyte maturation or other aspects of
endochondral ossification. In these studies, we microin-
jected concentrated Dlx5 retrovirus into the proximal pos-
terior portions of stage 21/22 (day 4) right chick wing buds,
which will give rise primarily to the humerus, ulna, and
radius. At various times after microinjection, the skeletons
of the embryos were stained with Alcian blue and Alizarin
Red to visualize cartilage and mineralized bone, respec-
tively.
At day 13 (Fig. 2) and day 18 (Fig. 3), the proximal skeletal
elements, particularly the humerus rudiments of the Dlx5
infected limbs are severely shortened. The humerus rudi-
ments of the Dlx5 infected limbs are on average 30.3 
3.2% shorter than their corresponding uninjected contralat-
eral control limbs at day 13 and 45.6  2.8% shorter at day
18. Furthermore, the length of the Dlx5-infected humerus
rudiments increases by only 13% between days 13 and 18,
whereas the length of the control rudiments increases by
50% during the same period. The radius and particularly
the ulna rudiments of the Dlx5-infected limbs are also
shorter than controls (ulna and radius 30.6  2.1% and
18.2  2.8% shorter, respectively on E18), although not to
quite the same extent as the humerus, whereas the distal
skeletal elements are little affected (91.2  2.1% the length
of controls on E18). This proximodistal difference in sever-
ity of effect is not unexpected, and reflects the fact that the
Dlx5 retrovirus was initially microinjected into the pro-
spective proximal portions of the limb bud at stage 21/22.
Consistent with this, when Dlx5 retrovirus is injected
throughout the distal posterior portion of the limb bud at an
earlier developmental stage (stage 17), shortening of the
digits (29.7  3.4% shorter than controls at E13) as well as
more proximal skeletal elements is detected (data not
shown). These results clearly indicate that misexpression of
Dlx5 inhibits the longitudinal growth of developing long
bones.
FIG. 1. Expression of Dlx5 in a metacarpal rudiment at day 6.
(A) Bright field. (B) Dark field. Dlx5 is expressed in the perichon-
drium (p, arrows) adjacent to the diaphysis of the cartilage
models that will give rise to the periosteal bony collar. Dlx5
is also expressed by the maturing prehypertrophic and
hypertrophic chondrocytes in the diaphysis of the cartilage
models, but not by the immature chondrocytes in the epiphyses
(ep).
FIG. 2. (A–C) Alcian blue/Alizarin Red-stained skeletal ele-
ments of day 13 contralateral control and Dlx5 infected limbs.
The control and Dlx5 infected humerus rudiments are shown at
higher magnification in (B, C). The humerus rudiments of the
Dlx5-infected limbs are severely shortened and characteristi-
cally misshapen and bent (C). The ulna and the radius of the
infected limbs are also shorter, but the distal skeletal elements
are little affected. Also note that narrow zones of chondrocytes
that stain very darkly with Alcian blue are present adjacent to
the marrow cavity in control skeletal elements (red arrows in B).
In the Dlx5-infected rudiments, the zone of darkly staining
chondrocytes is expanded and extends deeply into the marrow
cavity (red arrow in C).
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Interestingly, the humerus rudiments of the Dlx5-
infected limbs are not only considerably shorter, but are
also characteristically misshapen and bent (Figs. 2 and 3).
Although the reason for this characteristic bending is not
clear, it is possible that the impaired elongation of the Dlx5
infected humerus rudiments coupled with normal growth
of the surrounding nonskeletal tissues such as tendons
might result in such misshaping.
It is noteworthy that a narrow zone of chondrocytes that
stain very darkly with Alcian blue is present adjacent to the
marrow cavity in control skeletal elements (arrows in Fig.
2B). Significantly, in the Dlx5-infected skeletal elements,
the zone of darkly staining chondrocytes is greatly ex-
panded and extends deeply into the marrow cavity (arrow in
Figs. 2C). As described below, these darkly staining zones
consist of terminally differentiated hypertrophic chondro-
cytes detectable histologically and histochemically.
It is also noteworthy that the Alizarin Red-stained peri-
FIG. 3. (A, B) Alcian blue/Alizarin Red-stained skeletal elements of day 18 contralateral control (A) and Dlx5-infected (B) limbs. (C, D)
Higher magnification images of the control (C) and Dlx5-infected (D) humerus rudiments. The humerus rudiments of the Dlx5-infected
limbs are severely shortened and characteristically misshapen and bent (D). The ulna and the radius of the infected limbs are also shorter,
but the distal skeletal elements are little affected.
FIG. 4. Hematoxylin and eosin-stained sections through a contralateral control (A) and Dlx5-infected (B) humerus at day 18. The
Dlx5-infected humerus (B) contains an excessive number of enlarged rounded apparently hypertrophic chondrocytes (hy) that extend deeply
into the marrow cavity. There is also an increase in the amount of periosteal bone (bone) along the diaphysis of the Dlx5-infected humerus.
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osteal bony collars that form around the diaphyses of the
Dlx5-infected skeletal elements are broader than controls,
particularly at day 18 (Fig. 3). The Alizarin Red-stained
periosteal bony collars are 53  11% wider in the Dlx5-
infected humerus rudiments than in contralateral controls,
and the bony collars of the Dlx5-infected ulna and radius
rudiments are 32  1.6% and 22  2% wider than controls,
respectively. So, although Dlx5 misexpression inhibits lon-
gitudinal growth, it does not inhibit periosteal bone forma-
tion, and in fact seems to stimulate it (see below).
The Shortened Skeletal Elements Formed in
Response to Dlx5 Misexpression Contain Excessive
Numbers of Hypertrophying Chondrocytes
To gain further insight into the mechanism by which
Dlx5 misexpression inhibits the longitudinal growth of
developing long bones, control and Dlx5-infected skeletal
elements were sectioned and the histology of the skeletal
rudiments was examined after staining with hematoxylin
and eosin. As shown in Fig. 4, Dlx5-infected skeletal
elements contain an excessive number of enlarged rounded
cells morphologically resembling hypertrophying chondro-
cytes. Whereas control humerus rudiments have a rela-
tively small zone of large rounded hypertrophic chondro-
cytes adjacent to the marrow cavity, in the Dlx5-infected
rudiments, the zone of apparently hypertrophic chondro-
cytes is greatly expanded and extends deeply into the
marrow cavity of the diaphysis (Fig. 4). Furthermore, as
shown at high magnification in Fig. 5, in severely affected
Dlx5-infected skeletal elements, enlarged rounded cells
clearly resembling hypertrophying chondrocytes extend
into the metaphyseal and proximal epiphyseal regions that
are normally occupied by immature proliferating chondro-
cytes. These regions of contralateral control skeletal ele-
ments consist of adjacent organized groups of small
rounded and radially flattened chondrocytes which repre-
sent immature proliferating chondrocytes (Fig. 5) (Hart-
mann and Tabin, 2000). In contrast, the metaphyseal and
proximal epiphyseal regions of severely affected Dlx5 rudi-
ments contain relatively large numbers of enlarged rounded
cells morphologically resembling hypertrophying chondro-
cytes and lack the organized groups of small rounded and
radially flattened putative immature proliferating chondro-
cytes that are present throughout the corresponding regions
of controls (Fig. 5). These histological analyses suggest that
chondrocyte maturation is promoted as a consequence of
Dlx5 misexpression.
Although ectopic hypertrophic chondrocytes are present
in the proximal epiphyseal and metaphyseal region of
Dlx5-infected skeletal elements, they are rarely observed in
the epiphyseal region at the articular ends of the rudiments.
This suggests the interesting possibility that the chondro-
cytes directly subjacent to the periarticular perichondrium
are refractory or less sensitive to Dlx5 misexpression than
the immature proliferating chondrocytes in more proximal
regions of the epiphysis and in the metaphysis.
It is also noteworthy that there is an obvious increase
detectable histologically in the amount of periosteal bone
that is present along the diaphysis of the Dlx5-infected
humerus rudiments compared with contralateral controls
(Fig. 4), and this apparently accounts for the increased
thickness of the Alizarin Red-stained periosteal bony collar
detectable by whole-mount staining in the Dlx5 limbs.
Dlx5 Misexpression during Skeletal Differentiation
in Vivo Results in Expanded Domains of
Expression of Markers of Chondrocyte Maturation
To confirm the apparent striking expansion in the extent
of hypertrophic maturation detectable histologically in re-
sponse to Dlx5 misexpression and to gain further insight
into the mechanism of Dlx5 action during endochondral
ossification, we examined the effect of Dlx5 misexpression
on the expression of molecular markers of hypertrophic
chondrocyte maturation particularly osteopontin and type
X collagen. Osteopontin is a late marker of chondrocyte
maturation which is characteristically expressed by termi-
nally differentiated hypertrophic chondrocytes that are un-
dergoing mineralization (Gerstenfeld and Shapiro, 1996;
Iwamoto et al., 1993; Koyama et al., 1999). At day 13 (Fig. 6)
and day 18 (Fig. 7), the expression domain of osteopontin
detectable by in situ hybridization is greatly expanded in
the Dlx5-infected skeletal elements compared with unin-
fected contralateral controls. The length of the osteopontin
expression domain in the Dlx5-infected humerus rudiment
is expanded by about twofold compared with contralateral
controls. Not only is the expression domain of osteopontin
expanded, but there is also a striking increase in the
intensity of the osteopontin hybridization signal in the
Dlx5-infected elements compared with controls (Fig. 6). A
similar expansion in the expression domain of type X
collagen, a definitive molecular maker of hypertrophic
chondrocytes, is present in the Dlx5-infected skeletal ele-
ments (Fig. 7). Thus, the apparent expansion in the extent of
hypertrophic maturation detectable histologically in re-
sponse to Dlx5 misexpression is accompanied by expanded
and apparently upregulated domains of expression of mo-
lecular markers of hypertrophic chondrocyte maturation.
During terminal phases of maturation, the matrix sur-
rounding hypertrophic chondrocytes becomes progressively
mineralized. To further examine the effect of Dlx5 misex-
pression on maturation, sections through Dlx5-infected and
control skeletal elements were stained with Alizarin Red
which specifically binds to mineralized matrix. In day 13
control skeletal elements, Alizarin Red-stainable mineral-
ized cartilage matrix is limited to small regions of termi-
nally differentiated hypertrophic chondrocytes near the
bone marrow cavity (Fig. 8). As shown in Fig. 8, the region
of Alizarin Red-stained mineralized cartilage matrix is
greatly expanded in Dlx5-infected skeletal elements.
To study further the effects of Dlx5 on the regulation of
chondrocyte maturation, the expression domains of Ihh and
PTHrP were examined in control and Dlx5-infected skeletal
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elements. Although at day 13 there is an expansion in the
Ihh expression domain in Dlx5-infected skeletal elements,
the expression domain of PTHrP in the periarticular peri-
chondrium appears normal, and no ectopic expression of
PTHrP is detectable in the Dlx5-infected elements (Fig. 9).
Thus, Dlx5 does not appear to interfere with the Ihh/PTHrP
regulatory loop that negatively controls the progression of
proliferating chondrocytes to prehypertrophic chondro-
cytes.
As described above, in addition to enhanced chondrocyte
maturation, there is an increase in thickness of the perios-
teal bony collar along the diaphyses of the Dlx5 infected
skeletal elements compared with contralateral controls
detectable by whole-mount staining (Fig. 3) and histologi-
cally (Fig. 4). As shown in Fig. 10, the increase in the
amount of mineralized periosteal bone in response to Dlx5
misexpression is also clearly evident in Alizarin Red-
stained tissue sections, and is also reflected in an expanded
periosteal domain of expression of osteopontin, which is a
marker of differentiated osteoblasts as well as a late marker
of chondrocyte maturation. These results further suggest
that Dlx5 may be involved directly or indirectly in regulat-
ing osteoblast differentiation during the formation of the
periosteal bony collar, as well as in regulating chondrocyte
maturation.
Dlx5 Misexpression Markedly Reduces
Chondrocyte Proliferation as It Promotes
Maturation
At the onset of chondrocyte maturation, immature pro-
liferating chondrocytes exit the cell cycle concomitant with
initiating hypertrophic differentiation. As described above,
our histological analyses indicated that, in addition to an
enhancement of hypertrophic maturation, there was an
apparent decrease in the size of the zone of proliferation in
response to Dlx5 misexpression. In particular, Dlx5-
infected skeletal elements lack the organized groups of
rounded and radially flattened chondrocytes that constitute
the zones of proliferation in the metaphyseal regions of
control skeletal elements. To confirm and quantify the
apparent reduction in proliferation detectable histologically
in response to Dlx5 misexpression, we compared the ex-
pression of PCNA (proliferating cell nuclear antigen) by
FIG. 5. High-magnification images of hematoxylin and eosin-
stained sections through the proximal epiphyseal and metaphyseal
regions of day 18 control (A) and Dlx5-infected (B) humerus
rudiments. This region of the control rudiment (A) consists of
adjacent organized zones of small rounded (toward the left) and
radially flattened (toward the right) immature proliferating chon-
drocytes. The corresponding region of the Dlx5-infected rudiment
(B) contains large numbers of enlarged rounded cells resembling
hypertrophying chondrocytes. The images of the control and Dlx5-
infected rudiments are at equivalent distances (about 0.5 mm) from
the articular surfaces.
FIG. 6. Osteopontin expression in a contralateral control (A) and
Dlx5-infected (B) humerus rudiment at day 13. The osteopontin
expression domain is expanded in the Dlx5-infected humerus and
the hybridization signal is considerably more intense.
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immunohistochemistry in Dlx5-infected and control hu-
merus elements. PCNA is an accessory protein for DNA
polymerase that is synthesized in the late G1 and S phases
of the cell cycle and thus is specifically present in the nuclei
of dividing cells (Hall et al., 1990; Waseem and Lane, 1990).
As shown in Fig. 11, there is a striking reduction in the
number of PCNA-positive nuclei in the metaphyseal region
of Dlx5-infected skeletal elements compared with unin-
fected contralateral controls. Most of the nuclei of the
rounded and radially flattened immature chondrocytes in
the zone of proliferation in the metaphyseal region of
control skeletal elements are PCNA-positive. In contrast,
the metaphyseal region of the Dlx5-infected elements con-
tains far fewer PCNA-positive nuclei, and the majority of
the nuclei are unlabeled (Fig. 11). There is on average a
44.3% reduction in the proportion of dividing (PCNA-
positive) cells in the metaphyseal region of the Dlx5 in-
fected elements compared with contralateral controls.
Whereas 69.3  1.9% of the nuclei in the proliferation zone
of control humerus elements are PCNA-positive, only
FIG. 7. (A, B) Osteopontin (Opn) expression detectable by in situ
hybridization, and (C, D) type X collagen expression detectable by
immunostaining in adjacent sections of a contralateral control (A,
C) and Dlx5-infected (B, D) humerus rudiment at day 18. The
osteopontin and type X collagen expression domains are expanded
in the Dlx5-infected rudiment.
FIG. 8. Mineralized cartilage matrix detectable by Alizarin Red
staining in a contralateral control and Dlx5-infected humerus
rudiment at day 13. In the control, mineralized cartilage matrix
(arrows) is limited to small regions near the bone marrow cavity
(BMC). In the Dlx5-infected rudiment, the region of mineralized
cartilage matrix (bar) is greatly expanded.
FIG. 9. (A, B) Ihh and (C, D) PTHrP expression in contralateral
control (A, C) and Dlx5-infected (B, D) humerus rudiments at E13.
Although there is an expansion in the Ihh expression domain in the
Dlx5-infected rudiment, the expression of PTHrP in the periarticu-
lar perichondrium is unaffected.
FIG. 10. (A, B) Alizarin Red-stained periosteal bony collars in
control (A) and Dlx5-infected (B) humerus rudiments at day 13.
There is a striking increase amount of mineralized periosteal bone
in the Dlx5-infected rudiment. (C, D) Osteopontin (Opn) expres-
sion in the periosteal bony collars of control (C) and Dlx5-infected
(D) humerus rudiments. The increase in the amount of periosteal
bone in the infected rudiment is reflected in expanded osteopontin
expression.
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38.6  2.6% of the nuclei in the metaphyseal region of the
Dlx5-infected elements are labeled. The difference in pro-
liferation in Dlx5-infected and control elements is most
pronounced in the lower portion of the metaphysis, where
95.9  0.9% of the radially arranged chondrocytes in
control elements are proliferating, whereas only 30.5 
2.7% of the enlarged chondrocytes in the corresponding
region of Dlx5 infected rudiments are dividing. Thus, Dlx5
misexpression markedly reduces chondrocyte proliferation
as it promotes chondrocyte maturation.
DISCUSSION
Dlx5 Is a Positive Regulator of Chondrocyte
Maturation during Endochondral Ossification
The process of endochondral ossification in which the
bones of the limb are formed after the generation of carti-
lage models is dependent on a precisely regulated and
coordinated program of chondrocyte maturation. A crucial
event in chondrocyte maturation is differentiation of im-
mature proliferating chondrocytes into postmitotic prehy-
pertrophic chondrocytes which then undergo hypertrophy.
Hypertrophic maturation appears to be the main determi-
nant of longitudinal growth (Hunziker, 1994). Identification
of regulatory genes that control the progression of chondro-
cyte maturation toward hypertrophy is crucial to under-
standing normal and abnormal bone growth and develop-
ment.
The results of the present study indicate that the home-
odomain transcription factor Dlx5 is an important positive
regulator of chondrocyte maturation in the developing
skeletal elements of the limb. First, we demonstrate that
Dlx5 is expressed at the onset of chondrocyte maturation
during the conversion of immature proliferating chondro-
cytes into hypertrophying chondrocytes, which is a critical
step in the maturation process. Moreover, misexpression of
Dlx5 during the differentiation of the skeletal elements of
the chick limb in vivo promotes chondrocyte maturation
resulting in the formation of severely shortened skeletal
elements that contain excessive numbers of hypertrophying
chondrocytes extending into ectopic regions. In response to
Dlx5 misexpression, ectopic hypertrophying chondrocytes
not only extend deeply into the marrow cavity, but also are
present in the metaphyseal and proximal epiphyseal regions
that are normally occupied by immature proliferating chon-
drocytes. The expansion in the extent of hypertrophic
maturation in response to Dlx5 misexpression is accompa-
nied by expanded domains of expression of molecular
markers of hypertrophic chondrocyte maturation, particu-
larly osteopontin and type X collagen, and also by an
expansion of mineralized cartilage matrix, which is charac-
teristic of terminal hypertrophic differentiation. Finally,
Dlx5 misexpression markedly reduces chondrocyte prolif-
eration concomitant with promoting hypertrophic matura-
tion.
Taken together, these results indicate that Dlx5 is an
important positive regulator of chondrocyte maturation
during endochondral ossification and suggest that it may
FIG. 11. Cell proliferation detectable by PCNA immunohistochemistry in the metaphyseal region of a control (A) and Dlx5-infected (B)
humerus rudiment at day 18. There is a striking reduction in the number of PCNA-positive nuclei in the Dlx5-infected rudiment. On
average, there is about a 44% reduction in the proportion of dividing (PCNA positive) cells in the Dlx5-infected elements compared with
contralateral controls (see text for details).
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regulate maturation at least in part by promoting the
conversion of immature proliferating chondrocytes into
hypertrophying chondrocytes. This possibility is consistent
with our finding that during normal development Dlx5
expression is initiated concomitant with the conversion of
immature proliferating chondrocytes into postmitotic pre-
hypertrophic chondrocytes.
Since our gain-of-function study clearly implicates Dlx5
in the regulation of chondrocyte maturation, it is of con-
siderable interest that Dlx5-null mice exhibit no obvious
defects in the longitudinal growth of long bones or malfor-
mations of the limbs (Acampora et al., 1999; Depew et al.,
1999), although there is a subtle reduction of the periosteal
bone lamina and defects in craniofacial skeletogenesis
(Acampora et al., 1999). In this regard, it is noteworthy that
Dlx6, a closely related and potentially functionally redun-
dant member of the Dlx family, has been reported to be
coexpressed with Dlx5 during skeletogenesis (Simeone et
al., 1994; Acampora et al., 1999; Chen et al., 1996). Thus, in
the absence of Dlx5, Dlx6 or some other member of the Dlx
family may compensate for Dlx5 in regulating chondrocyte
maturation. It is therefore of considerable interest that
it has recently been demonstrated that chondrocyte matu-
ration is severely inhibited and retarded in mouse embryos
in which the Dlx5 and Dlx6 genes have been simulta-
neously inactivated (Robledo et al., 2002). This loss-of-
function study complements and confirms our gain-of-
function study, indicating that Dlx5 and other Dlx
genes are positive regulators of chondrocyte maturation
during endochondral ossification. The Dlx5/Dlx6 double
inactivation study also indicates that Dlx5, Dlx6, and
perhaps other members of the Dlx family function in a
redundant or concerted fashion to regulate chondrocyte
maturation.
Although our results clearly indicate Dlx5 is a positive
regulator of chondrocyte maturation, the extension of hy-
pertrophic chondrocytes into the marrow cavity in response
to Dlx5 misexpression might also reflect, at least in part,
alterations in mechanisms of remodeling or removal of the
hypertrophic zone. Alternatively, the rate of removal of the
hypertrophic chondrocytes in the marrow cavity might not
be able to keep pace with the enhanced rate of hypertrophic
maturation that occurs in response to Dlx5 misexpression.
In any case, the possibility that Dlx5 may be involved in
remodeling as well as in chondrocyte maturation warrants
consideration.
Possible Relationships between Dlx5 and Other
Regulators of Chondrocyte Maturation during
Endochondral Ossification
In addition to Dlx5, several other regulatory molecules,
including BMPs, particularly BMP-6, the transcription fac-
tor Cbfa1/Runx2, and -catenin-mediated Wnt signaling,
have been implicated in the positive regulation of chondro-
cyte maturation during endochondral ossification (see In-
troduction). Unraveling the ways in which Dlx5 and other
transcription factors and signaling pathways interact and
cooperate with one another to regulate the progression of
hypertrophic chondrocyte maturation is critical to under-
standing the differentiation and growth of the skeletal
elements of the limbs. Although the relationships between
Dlx5 and the other positive regulators of maturation remain
to be determined, previous studies are suggestive of several
possible regulatory interactions.
Like Dlx5, BMP-6, which can stimulate chondrocyte
maturation in vitro (Grimsrud et al., 1999; Ito et al., 1999;
Kameda et al., 2000; Boskey et al., 2002), is expressed in
prehypertrophic and hypertrophic chondrocytes in vivo
(Kingsley, 1994; Vortkamp et al., 1996; Inada et al., 1999). It
is therefore noteworthy that Dlx5 is a direct downstream
target gene of BMP signaling in osteoblasts (Miyama et al.,
1999) and other cell types (Luo et al., 2001; Park and
Morasso, 2002). Thus, it is possible that Dlx5 expression
may be regulated by BMP-6 or another member of the BMP
family during chondrocyte maturation. If so, Dlx5 may
participate in mediating at least some of the positive effects
of BMP signaling on hypertrophic differentiation. It is also
possible that Dlx5 and BMP-activated Smad transcription
factors, such as Smads 1, 5, or 8, might function as coacti-
vators of the transcription of some target genes during
chondrocyte maturation. Both homeodomain binding ele-
ments and BMP responsive Smad binding elements are
involved in regulation of the osteopontin gene promoter in
osteoblasts (Hullinger et al., 2001), and the osteopontin
gene is a candidate direct target of Dlx5 during chondrocyte
maturation, since its expression domain is expanded and
upregulated in response to Dlx5 misexpression.
Cbfa1/Runx2, another positive regulator of chondrocyte
maturation, is coexpressed with Dlx5 and BMP-6 by prehy-
pertrophic and hypertrophic chondrocytes of the cartilage
models (Inada et al., 1999; Kim et al., 1999), and the skeletal
elements of Cbfa1/Runx2 knockout mice in which chon-
drocyte maturation is suppressed do not express BMP-6
(Inada et al., 1999). Thus, it is possible that Cbfa1/Runx2
might be an upstream regulator of BMP-6 expression at the
onset of hypertrophic differentiation, and, in turn, as de-
scribed above, BMP signaling may regulate the expression
of Dlx5. Conversely, several studies have shown that BMP
signaling can upregulate the expression of Cbfa1/Runx2 in
osteoblasts (Chen et al., 1998; Lee et al., 1999, 2000; Gori et
al., 1999; Bannerjee et al., 2001) and in a chondrocyte-like
cell line, TC6 (Takazawa et al., 2000). Thus, BMP signaling
has the potential to regulate expression of both Dlx5 and
Cbfa1/Runx2 during chondrocyte maturation, and these
transcription factors may then function separately or work
together as comodulators of some target genes in chondro-
cytes, perhaps in conjunction with BMP-activated Smad
transcription factors. It is indeed noteworthy that the
pattern of expression of Cbfa1/Runx2 is modified in Dlx5/
6/ mutant mouse embryos (Robledo et al., 2002).
Several observations suggest that it is also possible that
Dlx5 may interact or cooperate with -catenin-mediated
Wnt signaling in positively regulating chondrocyte matura-
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tion. The effects of retroviral misexpression of Wnt-4 or
activated -catenin during skeletal development in the
chick limb (Hartmann and Tabin, 2000) are quite similar to
those we observe as a consequence of misexpression of
Dlx5. Misexpression of each not only promotes chondro-
cyte maturation resulting in the formation of shortened
skeletal elements containing excess numbers of hypertro-
phying chondrocytes, but misexpression of each also stimu-
lates periosteal bone formation. These similar phenotypic
effects suggest there may be a direct regulatory relationship
between -catenin-mediated Wnt signaling and Dlx5 in the
positive control of chondrocyte maturation. Thus, it is
noteworthy that the expression of Dlx genes is regulated by
-catenin-mediated Wnt signaling in some developing sys-
tems (Neumann and Cohen, 1997; Beanan et al., 2000). In
particular, during development of the wing imaginal disc in
Drosophila, Distal-less, the Drosophila homolog of verte-
brate Dlx genes, is a target gene of Wingless, the Drosophila
homolog of Wnt-1, which signals through the canonical
-catenin pathway ((Neumann and Cohen, 1997). Taken
together, these results suggest the possibility that Dlx5
might participate in mediating at least some of the effects of
the -catenin Wnt signaling pathway during chondrocyte
maturation, and/or that the Wnt signaling pathway and
Dlx5 may work together in regulating the process.
Dlx5 May Also Be Involved in Regulating
Osteoblast Differentiation during Formation of the
Periosteal Bony Collar
In addition to promoting chondrocyte maturation in the
cartilage models, Dlx5 misexpression enhances periosteal
bone formation. Conversely, periosteal bone formation is
severely reduced and retarded in Dlx5/6/ mutant mouse
embryos (Robledo et al., 2002). The increase in periosteal
bone we observe as a result of Dlx5 misexpression could
result from Dlx5 directly promoting enhanced osteoblast
differentiation from osteogenic precursor cells in the peri-
osteum, or it may be a secondary consequence of the
enhanced chondrocyte maturation that is occurring result-
ing in enhanced osteogenic signaling from the maturing
chondrocytes to the periosteum. Although the latter possi-
bility cannot be excluded, several observations suggest that
Dlx5 may play a direct role in regulation of osteoblast
differentiation during formation of the periosteal bony
collar.
During normal development, Dlx5 is highly expressed by
the perichondrium adjacent to the diaphysis of the models
that will give rise to the osteoblasts that deposit the
periosteal bony collar. As endochondral ossification pro-
ceeds, Dlx5 is indeed very highly expressed in the inner
layers of the periosteum, where osteoblasts are differentiat-
ing and depositing periosteal bone. Dlx5 is also expressed by
differentiating osteoblasts during intramembranous ossifi-
cation (Simeone et al., 1994; Zhao et al., 1994). Further-
more, we have found that retroviral overexpression of Dlx5
in primary cultures of chick embryo calvarial cells dramati-
cally accelerates osteoblast differentiation and prematurely
induces expression of several osteoblast markers (Tadic et
al., 2002). Dlx5 also stimulates osteoblastic differentiation
of calvarial periosteal cells that do not normally undergo
osteoblastic differentiation in vitro (Tadic et al., 2002).
Overexpression of Dlx5 also upregulates production of
osteocalcin and mineralization in MC3T3 osteoblast cells
(Miyama et al., 1999). Dlx5 has been directly implicated in
the transcriptional activation of several osteoblast genes,
including Col1a1 (Tadic et al., 2001), bone sialoprotein
(Benson et al., 2000), and osteocalcin (Newberry et al.,
1998). Taken together, these observations suggest that Dlx5
may be directly involved in regulating osteoblast differen-
tiation during the formation of the periosteal bony collar, as
well as in regulating chondrocyte maturation.
It is possible that the increase in periosteal bone in
response to Dlx5 misexpression could result in part from
decreased turnover or remodeling of periosteal bone. How-
ever, an increase in periosteal bone formation is detectable
in Dlx5-infected skeletal rudiments as early as day 13,
which is before significant remodeling and turnover of the
periosteal bone at its inner (endosteal) surface normally
occurs (Pechak et al., 1986b).
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